Effects of Growth Hormone (GH) Treatment on Eating Regulation
NCT00562705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2013-07-16
Summary
This is a two arm, randomized, prospective, intervention study in order to determine the effects of growth hormone treatment on eating regulation and to compare between the growth responses with or without nutritional intervention in short stature children.
The study will include 30 short stature children that are about to initiate growth hormone treatment and will last for one year. After 4 months of treatment, children will be randomized into two groups:
1. Control group that will continue with growth hormone treatment without any other intervention.
2. Study group that will be a given a nutritional intervention in addition to growth hormone treatment.
At screening visit and during the study the following parameters will be evaluated: height, weight, growth markers in the blood and urine, child eating behavior questionnaire, blood tests, hormonal tests and resting energy expenditure measurements.
Conditions
- Short Stature
Interventions
- BEHAVIORAL
-
growth hormone- Genotropin or NorditropinSimplex and nutritional intervention
A combined treatment of growth hormone (Genotropin or NorditropinSimplex or "Biotropin") and nutritional intervention
- BEHAVIORAL
-
growth hormone-Genotropin or NorditropinSimplex or "Biotropin"
Growth hormone treatment (Genotropin, or NorditropinSimplex or "Biotropin").
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Moshe Phillip, Professor · Schneider Children Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02976675 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy
NCT04962360 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Interactions Between Growth Hormone and the Microbiome
NCT03327207 ·Status: UNKNOWN
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NCT02968004 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
NCT07226089 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
NCT06103513 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients
NCT02042170 ·Status: COMPLETED ·Phase: PHASE2
-
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 ·Status: COMPLETED ·Phase: PHASE3
-
Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
NCT01342146 ·Status: COMPLETED ·Phase: PHASE2
-
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT00458263 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Use Investigation of Somatropin for GHD-ADULTS.
NCT00601419 ·Status: COMPLETED
-
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
NCT00102817 ·Status: COMPLETED ·Phase: PHASE3
-
Nutrients and Hormones: Effects in Boys With Disordered Growth
NCT00139451 ·Status: COMPLETED ·Phase: PHASE2
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
NCT03005561 ·Status: UNKNOWN ·Phase: NA
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
NCT01562834 ·Status: COMPLETED ·Phase: PHASE4
-
Genotropin Treatment In Very Young Children Born Small For Gestational Age
NCT00627523 ·Status: COMPLETED ·Phase: PHASE3